Compare Cintas Corporation (CTAS) vs Humana Inc (HUM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cintas Corporation vs Humana Inc — how do they compare? Cintas Corporation trades at $202.41 (market cap $79.86B), while Humana Inc trades at $431.03 (market cap $46.49B). The key difference: Cintas Corporation is the larger of the two by market cap, and Cintas Corporation pays the higher dividend (1.03%). Which is the better fit depends on your goals — on Pluang, investors hold Cintas Corporation for 125 Days and Humana Inc for 51 Days on average.
| CTAS | HUM | |
|---|---|---|
Market Cap | $79.86B | $46.49B |
Volume | 1,323,583 | 2,567,704 |
Sector | Industrials | Health |
52-Week High | $216.53 | $409.85 |
52-Week Low | $163.55 | $163.67 |
Typical Hold Time | 125 Days | 51 Days |
Enterprise Value | $82.33B | $53.84B |
Dividend Yield | 1.03% | 0.91% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cintas (CTAS) trades at $202.41, up 2.65% on the day, reflecting strong momentum after recent earnings beat. The stock exhibits a bullish technical setup with price above key moving averages. Fundamentally, the company reported Q1 2027 revenue of $3.01 billion, a 10.9% YoY increase, with earnings per share of $1.39 surpassing estimates. Robust profitability is evident with a net income margin of 17.82% and ROE of 41.25%. Recent news highlights raised fiscal 2027 guidance, signaling management confidence in continued growth driven by organic expansion and margin gains.
The outlook for CTAS remains positive, supported by consistent revenue growth, high profitability, and bullish analyst sentiment with a consensus price target of $234.60. Key opportunities include sustained demand for uniform rental and workplace services, while risks involve elevated valuation multiples and potential economic sensitivity. The stock's current trajectory suggests further upside if execution remains strong, though investors should monitor margin sustainability and competitive pressures.
Humana (HUM) trades at $431.03, up 8.71% over the past day, reflecting strong momentum following a Barclays upgrade and positive earnings beats. The stock exhibits a bullish technical trend, with support at $378 and resistance at $394. Revenue has grown steadily from $92.9B in 2022 to $129.7B in 2025, though net income margins have compressed to 0.88%. Analyst consensus is a Buy with a $457.05 price target, and recent news highlights corporate initiatives and institutional investments.
The outlook for HUM is cautiously optimistic, driven by revenue growth and analyst support, but risks include margin pressure and regulatory scrutiny. Investment opportunity lies in execution of Medicare Advantage strategies, while key risks involve competitive pressures and potential fiduciary concerns highlighted in recent shareholder notices.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cintas Corporation
In its core uniform and facility services unit (78% of sales), Cintas provides uniform rental programs to businesses across the size spectrum, mostly in North America. The firm is by far the largest provider in the industry. Facilities products generally include the rental and sale of entrance mat, mops, shop towels, hand sanitizers, and restroom supplies. Cintas also runs a first aid and safety services business (11% of sales), a fire protection services business (7% of sales), and a uniform direct sales business (4% of sales).
Read more on CTAS →About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →
